Background illustration for clinical trials search

Kidney Disease Clinical Trials

Browse 751 Kidney Disease clinical trials enrolling across the United States and Canada. 69 people applied to Kidney Disease studies last month. Search by city or state to find one near you.

Filter
1

Effectiveness of Remote Ischemic Preconditioning for Prevention of Contrast Induced Acute Kidney Injury in Patients Undergoing Coronary Angiograms.

for
Contrast-induced Acute Kidney Injury (CI-AKI) Following Coronary Angiogram (CI-AKI),
Location: Galveston TX
Sponsor: The University of Texas Medical Branch, Galveston

Sex: All

Age: 18+

Code: NCT05147831

Recruiting

Flywheel Exercise for CKD

for
Chronic Kidney Disease stage3, Chronic Kidney Disease stage4
Location: Washington DC
Sponsor: Washington D.C. Veterans Affairs Medical Center

Sex: All

Age: 18 - 70+

Code: NCT03582982

Recruiting

CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus

for
SLE, Systemic Lupus Erythematosus (SLE), CAR T Cell, CART19,
Location: Philadelphia PA
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 10 - 29

Code: NCT06839976

Phase 1, Phase 2, Recruiting

NO During CPB in Neonates to Reduce Risk of AKI

for
AKI, CHD - Congenital Heart Disease, Surgery
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 0

Code: NCT04216927

Phase 3, Recruiting

A Prospective Observational Study of Foam Sclerotherapy .

for
Autosomal Dominant Polycystic Kidney, Renal Cyst,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18 - 70+

Code: NCT04111692

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Exercise in Patients With End Stage Kidney Disease

for
Renal Failure
Location: Ottawa
Sponsor: Ottawa Hospital Research Institute

Sex: All

Age: 18+

Code: NCT03787589

Recruiting

Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC

for
Advanced Cancer, Clear Cell Renal Cell Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05663710

Phase 1, Phase 2, Recruiting

Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury

for
Acute Kidney Injury
Location: Houston TX
Sponsor: Hope Biosciences LLC

Sex: All

Age: 18 - 70+

Code: NCT06654193

Phase 1, Phase 2, Recruiting

A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide

for
End Stage Renal Disease, Renal Impairment, Obesity, Overweight
Location: Orlando FL, San Antonio TX
Sponsor: Kailera

Sex: All

Age: 18 - 70+

Code: NCT07793929

Phase 1, Recruiting

A Phase 3 Study of Inebilizumab in Participants With Primary Membranous Nephropathy

for
Glomerulonephritis, Membranous
Location: Doral FL, Miami FL, Pembroke Pines FL, Los Angeles CA
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07851220

Phase 3, Recruiting

Infliximab for Immune Checkpoint Inhibitor Associated AKI

for
Acute Kidney Injury, Acute Interstitial Nephritis
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT07683975

Recruiting

Effects of VX-407 on the Pharmacokinetics of Combined Oral Contraceptives

for
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Location: Montreal
Sponsor: Vertex Pharmaceuticals Incorporated

Sex: Female

Age: 18 - 50

Code: NCT07792408

Phase 1, Recruiting

A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

for
Primary IgA Nephropathy
Location: New York NY
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT04557462

Phase 3, Recruiting

Post-Filter Hematocrit

for
Continuous Renal Replacement Therapy, Renal Failure,
Location: Iowa City IA
Sponsor: Gwyndolyn M. Radford

Sex: All

Age: 18+

Code: NCT07293936

Recruiting

Casdatifan for the Treatment of Refractory Metastatic Clear Cell Renal Cell Carcinoma

for
Refractory Clear Cell Renal Cell Carcinoma,
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT07748988

Phase 1, Recruiting

A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)

for
Renal Insufficiency, Chronic
Location: Savannah GA, Charlotte NC, Waterloo, Riverview FL,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07624305

Phase 3, Recruiting

Delayed Tolerance Through Mixed Chimerism

for
Kidney Failure, Kidney Transplant; Complications, Chimera
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18 - 65

Code: NCT05900401

Phase 1, Phase 2, Recruiting

Phase II Trial of Sacituzumab Tirumotecan in Patients With SMARCB1-Deficient Renal Medullary Carcinoma

for
Phase II, Sacituzumab, Tirumotecan,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07438626

Phase 2, Recruiting

Photodynamic Diagnosis of Kidney Cancer Using Fluorescence Endoscopy and Oral 5-ALA

for
Kidney Cancers
Location: Detroit MI
Sponsor: Henry Ford Health System

Sex: All

Age: 18 - 70+

Code: NCT07828704

Phase 2, Recruiting

Lifestyle Intervention In CKD

for
Chronic Kidney Disease, Hypertension
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT07633145

Recruiting

What are clinical trials for kidney disease?

Clinical trials for kidney disease are research studies designed to test new treatments, interventions, or diagnostic methods aimed at improving the management and outcomes of kidney conditions including kidney disease. These trials may involve experimental medications, innovative therapies, surgical techniques, or lifestyle interventions.

The importance of kidney disease clinical trials

Kidney disease clinical trials are crucial because they help advance our understanding of kidney disorders so that more effective treatments can be developed. These trials test new drugs, therapies, and diagnostic methods, aiming to improve patient outcomes, slow disease progression, and enhance quality of life.

Clinical trials for kidney disease also provide valuable data on the safety and efficacy of new interventions, which can lead to better management strategies and potential cures. Without clinical trials, the development of innovative solutions and improvements in care for kidney disease would be limited, potentially leaving patients with fewer options and suboptimal outcomes.

Types of kidney disease clinical trials

Participation in a clinical trial for kidney disease

Who can take part in a kidney disease clinical trial?

How to enroll in a clinical trial for kidney disease